Springer
Junior Investigator Award Lecture TBD - award is based on abstract submission and an application Click here for application information
Not exact matches
Cancer Research Institute inaugurates its
Investigator Award Program for
junior faculty members working in immunology and tumor immunology.
One of ASH's most prestigious
award programs, the ASH Scholar
Awards financially support fellows and
junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent
investigators.
The prestigious ASH
Award supports fellows and
junior faculty transitioning from trainee to independent
investigator.
Analyses were conducted for all applications combined as well as separately for R01 applications (grant applications submitted by individual
investigators), other R applications (academic research enhancement
awards, exploratory / development grants, small grant program, small business
awards), and applications in the K (clinical research training
awards for
junior and midcareer faculty), P (program projects and center grants), and F (predoctoral and postdoctoral fellowships) series.
The
award applications, which are open to students,
junior investigators and senior
investigators, are due on May 15
Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly innovative pilot projects focusing on proof - of - concept or translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant
awards or clinical trial; (3) projects that closely align with the Cancer Center's strategic plan and enhance key initiatives; and (4) pilot funding for
junior investigators to jump - start independent projects or for more senior
investigators looking to study a novel idea derived from discovery.
The Young
Investigator Awards offer career and project support for young (generally 35 and younger) proven
investigators in postdoctoral fellowships or who have recently achieved
junior faculty positions and are committing their lives to the field of prostate cancer.